Skip to main content

Symbiotic transcatheter pacemaker for lifelong energy regeneration and therapeutic function in porcine disease model.

Nature biomedical engineering2026-01-21PubMed
Total: 86.0Innovation: 10Impact: 0Rigor: 0Citation: 0

Summary

A magnetically levitated, biocompatible transcatheter pacemaker harvested cardiac motion to exceed energy thresholds for lifelong service, achieving month-long autonomous pacing in a porcine brady-arrhythmia model. The design minimizes mechanical losses and enables interventional delivery, suggesting a path toward lifelong, maintenance-free pacing.

Key Findings

  • Electromagnetic induction with a magnetic levitation energy cache achieved near-zero boot threshold and high kinetic-to-electric conversion efficiency in intracardiac conditions.
  • A small, hemocompatible, interventional form factor enabled successful transcatheter delivery and month-long autonomous pacing in a porcine brady-arrhythmia model.
  • Energy regeneration surpassed the critical energy condition required for lifelong pacemaker operation, indicating a pathway toward maintenance-free pacing.

Clinical Implications

If validated in humans, energy-harvesting pacemakers could reduce generator replacements, infection risk, and healthcare costs, while enabling new form factors for minimally invasive implantation and lifelong pacing.

Why It Matters

This device engineering breakthrough directly addresses battery longevity and reintervention risks by enabling in situ energy harvesting, a potential paradigm shift in pacing therapy. Demonstration in a large-animal model underscores translational feasibility.

Limitations

  • Preclinical study; human hemodynamics, long-term durability, and thrombogenicity remain untested.
  • Performance beyond one month and under variable rhythm/pressure conditions requires evaluation.

Future Directions

Iterative device optimization and chronic large-animal studies assessing durability, hemocompatibility, arrhythmia sensing/pacing integration, followed by first-in-human feasibility trials.

Study Information

Study Type
Basic/Mechanistic research
Research Domain
Treatment/Device Innovation
Evidence Level
V - Preclinical device validation in a porcine model without human clinical outcomes.
Study Design
OTHER